StemCell Therapy

Odonate Therapeutics Inc (ODT) is near the top in its industry group according to InvestorsObserver. ODT gets an overall rating of 46. That means it scores higher than 46 percent of stocks. Odonate Therapeutics Inc gets a 51 rank in the Biotechnology industry. Biotechnology is number 63 out of 148 industries.

Click Here to get the full Stock Score Report on Odonate Therapeutics Inc (ODT) Stock.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Odonate Therapeutics Inc (ODT) stock is down -3.69% while the S&P 500 has gained 0.03% as of 9:57 AM on Friday, Dec 27. ODT is down -$1.09 from the previous closing price of $29.53 on volume of 2,310 shares. Over the past year the S&P 500 is higher by 30.22% while ODT has gained 141.43%. ODT lost -$4.36 per share the over the last 12 months.

To see the top 5 stocks in Biotechnology click here.

More here:
Is Odonate Therapeutics Inc (ODT) a Winner or a Loser in the Biotechnology Industry - InvestorsObserver

This entry was posted on December 28, 2019 at 9:51 am and is filed under Biotechnology. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |